These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32350221)

  • 1. Rapid Detection of Microbial Contamination in Intravenous Fluids by ATP-Based Monitoring System.
    Oie S; Kamiya A; Yamasaki H; Kouda K; Furukawa H; Tsuruta R
    Jpn J Infect Dis; 2020 Sep; 73(5):363-365. PubMed ID: 32350221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-return valves do not prevent backflow and bacterial contamination of intravenous infusions.
    Ellger B; Kiski D; Diem E; van den Heuvel I; Freise H; Van Aken H; Hinder F; Friedrich AW
    J Hosp Infect; 2011 May; 78(1):31-5. PubMed ID: 21397357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the standard pour plate procedure and the ATP and Limulus amebocyte lysate procedures for the detection of microbial contamination in intravenous fluids.
    Anderson RL; Highsmith AK; Holland BW
    J Clin Microbiol; 1986 Mar; 23(3):465-8. PubMed ID: 3514657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems of microbial contamination and sterility when administering drugs intravenously].
    Opulchenova G; Gencheva G
    Khirurgiia (Sofiia); 1983; 36(5):471-4. PubMed ID: 6366342
    [No Abstract]   [Full Text] [Related]  

  • 5. Extended drip infusion of peripheral parental nutrition containing amino acids might be associated with Bacillus cereus bloodstream infection.
    Shiota A; Asai N; Koizumi Y; Watanabe H; Sakata M; Kurumiya A; Takahashi T; Muramatsu Y; Hagihara M; Suematsu H; Yamagishi Y; Mikamo H
    Am J Infect Control; 2019 Sep; 47(9):1154-1156. PubMed ID: 31047689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastoschizomyces capitatus infection after contamination of fluids for intravenous application.
    Mathews MS; Sen S
    Mycoses; 1998 Nov; 41(9-10):427-8. PubMed ID: 9916469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine triphosphate bioluminescence analysis for rapid screening of microbial contamination in non-sterile pharmaceutical samples.
    Jimenez L
    PDA J Pharm Sci Technol; 2004; 58(3):159-68. PubMed ID: 15233255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and abuse of intravenous solutions.
    Vidt DG
    JAMA; 1975 May; 232(5):533-6. PubMed ID: 804572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines.
    Rapaport E; Salikhova A; Abraham EH
    Purinergic Signal; 2015 Jun; 11(2):251-62. PubMed ID: 25917594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing and controlling microbial contamination in cell cultures.
    Coté R
    Curr Protoc Cell Biol; 2001 May; Chapter 1():Unit 1.5. PubMed ID: 18228293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luciferase assay to detect bacterial contamination of intravenous fluids.
    Bopp CA; Wachsmuth IK
    Am J Hosp Pharm; 1981 Nov; 38(11):1747-50. PubMed ID: 7304631
    [No Abstract]   [Full Text] [Related]  

  • 12. The growth of micro-organisms in intravenous fluids.
    Garcia-Caballero J; Herruzo-Cabrera H; Vera-Cortes ML; Garcia de Lorenzo A; Vazquez-Encinar A; Garcia-Caballero F; del Rey-Calero J
    J Hosp Infect; 1985 Jun; 6(2):154-7. PubMed ID: 2862189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of Serratia marcescens infection due to contamination of multiple-dose vial of heparin-saline solution used to flush deep venous catheters or peripheral trocars.
    Liu D; Zhang LP; Huang SF; Wang Z; Chen P; Wang H; Cheng Y
    J Hosp Infect; 2011 Feb; 77(2):175-6. PubMed ID: 21194795
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microfilters within the scope of infusion therapy--possibilities and problems in retention of microbial and particle contaminants].
    Bach A; Böttiger BW
    Zentralbl Chir; 1994; 119(4):268-75. PubMed ID: 8203178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exponential ATP amplification through simultaneous regeneration from AMP and pyrophosphate for luminescence detection of bacteria.
    Lee HJ; Ho MR; Tseng CS; Hsu CY; Huang MS; Peng HL; Chang HY
    Anal Biochem; 2011 Nov; 418(1):19-23. PubMed ID: 21810404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal timing for intravenous administration set replacement.
    Gillies D; O'Riordan L; Wallen M; Morrison A; Rankin K; Nagy S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003588. PubMed ID: 16235329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prodigiosin formation in Serratia marcescens by adenosine triphosphate.
    Lawanson AO; Sholeye FO
    Experientia; 1976 Apr; 32(4):439-40. PubMed ID: 773662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of changing intravenous delivery systems at longer than 24-hour intervals.
    Band JD; Maki DG
    Ann Intern Med; 1979 Aug; 91(2):173-8. PubMed ID: 111593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of contamination from air vents during intravenous fluid administration.
    Useh MF; Mbouda B
    East Afr Med J; 1998 Jun; 75(6):322-6. PubMed ID: 9803611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serratia marcescens nosocomial outbreak due to contamination of hexetidine solution.
    Bosi C; Davin-Regli A; Charrel R; Rocca B; Monnet D; Bollet C
    J Hosp Infect; 1996 Jul; 33(3):217-24. PubMed ID: 8827508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.